Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Allard
Aurore
A
INSERM Unit 605, Villejuif, France.
Haddy
Nadia
N
Le Deley
Marie-Cécile
MC
Rubino
Carole
C
Lassalle
Mathilde
M
Samsaldin
Akthar
A
Quiniou
Eric
E
Chompret
Agnès
A
Lefkopoulos
Dimitri
D
Diallo
Ibrahima
I
de Vathaire
Florent
F
D000293:Adolescent; D000465:Algorithms; D018943:Anthracyclines / Q000008:administration & dosage; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects; D001853:Bone Marrow / Q000528:radiation effects*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005602:France; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute; D007953:Leukemia, Radiation-Induced / Q000175:diagnosis / Q000209:etiology*; D016013:Likelihood Functions; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000209:etiology*; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011034:Podophyllotoxin / Q000008:administration & dosage / Q000009:adverse effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D011879:Radiotherapy Dosage; D018570:Risk Assessment
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D011034:Podophyllotoxin